Polymorphisms in the NOS3, DDAH1, DDAH2, and AGXT2 genes have previously been shown to relate to NO-mediated vascular function, hypertension, and mortality in a range of different patient populations [13,14,15]. This evidence concerns the gene DDAH2 and Hypertension.